Literature DB >> 15711956

Elevated levels of asymmetric di-methylarginine in neonates with congenital diaphragmatic hernia.

Christine M Pierce1, Steven Krywawych, Andy J Petros.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15711956     DOI: 10.1007/s00431-005-1628-9

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  5 in total

1.  Determination of arginine and methylated arginines in human plasma by liquid chromatography-tandem mass spectrometry.

Authors:  K Vishwanathan; R L Tackett; J T Stewart; M G Bartlett
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2000-10-01

2.  Plasma levels of asymmetrical dimethyl-L-arginine in patients with congenital heart disease and pulmonary hypertension.

Authors:  M Gorenflo; C Zheng; E Werle; W Fiehn; H E Ulmer
Journal:  J Cardiovasc Pharmacol       Date:  2001-04       Impact factor: 3.105

Review 3.  Inhalational nitric oxide: a selective pulmonary vasodilator for treatment of persistent pulmonary hypertension of the newborn.

Authors:  R L Geggel
Journal:  J Pediatr       Date:  1993-07       Impact factor: 4.406

4.  Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase.

Authors:  R J MacAllister; H Parry; M Kimoto; T Ogawa; R J Russell; H Hodson; G S Whitley; P Vallance
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

5.  Quantitative determination of circulating and urinary asymmetric dimethylarginine (ADMA) in humans by gas chromatography-tandem mass spectrometry as methyl ester tri(N-pentafluoropropionyl) derivative.

Authors:  Dimitrios Tsikas; Bibiana Schubert; Frank-Mathias Gutzki; Jörg Sandmann; Jürgen C Frölich
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2003-12-05       Impact factor: 3.205

  5 in total
  1 in total

1.  Looking beyond PPHN: the unmet challenge of chronic progressive pulmonary hypertension in the newborn.

Authors:  Candice D Fike; Judy L Aschner
Journal:  Pulm Circ       Date:  2013-11-19       Impact factor: 3.017

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.